Related Experiment Video
Updated: Oct 5, 2025

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Small-Molecule Compound SYG-180-2-2 to Effectively Prevent the Biofilm Formation of Methicillin-Resistant
Lulin Rao1, Yaoguang Sheng2, Jiao Zhang1
1Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Abstract:
The resistance of methicillin-resistant Staphylococcus aureus (MRSA) has augmented due to the abuse of antibiotics, bringing about difficulties in the treatment of infection especially with the formation of biofilm. Thus, it is essential to develop antimicrobials. Here we synthesized a novel small-molecule compound, which we termed SYG-180-2-2 (C21H16N2OSe), that had antibiofilm activity. The aim of this study was to demonstrate the antibiofilm effect of SYG-180-2-2 against clinical MRSA isolates at a subinhibitory concentration (4 μg/ml). In this study, it was showed that significant suppression in biofilm formation occurred with SYG-180-2-2 treatment, the inhibition ranged between 65.0 and 85.2%. Subsequently, confocal laser scanning microscopy and a bacterial biofilm metabolism activity assay further demonstrated that SYG-180-2-2 could suppress biofilm. Additionally, SYG-180-2-2 reduced bacterial adhesion and polysaccharide intercellular adhesin (PIA) production. It was found that the expression of icaA and other biofilm-related genes were downregulated as evaluated by RT-qPCR. At the same time, icaR and codY were upregulated when biofilms were treated with SYG-180-2-2. Based on the above results, we speculate that SYG-180-2-2 inhibits the formation of biofilm by affecting cell adhesion and the expression of genes related to PIA production. Above all, SYG-180-2-2 had no toxic effects on human normal alveolar epithelial cells BEAS-2B. Collectively, the small-molecule compound SYG-180-2-2 is a safe and effective antibacterial agent for inhibiting MRSA biofilm.
Insights
A novel compound, SYG-180-2-2, effectively inhibits methicillin-resistant Staphylococcus aureus (MRSA) biofilm formation by downregulating key genes. This safe and potent agent shows promise for treating challenging MRSA infections.
Area of Science:
- Microbiology
- Drug Discovery
- Antimicrobial Resistance
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to antibiotic resistance and biofilm formation, complicating treatment.
- The development of novel antimicrobials is crucial to combat persistent MRSA infections, particularly those involving biofilms.
Purpose of the Study:
- To evaluate the antibiofilm efficacy of a novel small-molecule compound, SYG-180-2-2, against clinical MRSA isolates.
- To elucidate the mechanism of action of SYG-180-2-2 in suppressing MRSA biofilm formation.
Main Methods:
- SYG-180-2-2 was tested at a subinhibitory concentration (4 μg/ml) against clinical MRSA isolates.
- Biofilm formation was assessed using confocal laser scanning microscopy and a bacterial biofilm metabolism activity assay.
- Gene expression analysis (RT-qPCR) was performed to investigate the impact on biofilm-related genes, including icaA, icaR, and codY.
- Cytotoxicity was evaluated using human normal alveolar epithelial cells (BEAS-2B).
Main Results:
- SYG-180-2-2 significantly suppressed MRSA biofilm formation, with inhibition ranging from 65.0% to 85.2%.
- The compound reduced bacterial adhesion and polysaccharide intercellular adhesin (PIA) production.
- SYG-180-2-2 downregulated the expression of icaA and other biofilm-related genes while upregulating icaR and codY.
- No toxic effects were observed on BEAS-2B cells.
Conclusions:
- SYG-180-2-2 effectively inhibits MRSA biofilm formation by targeting cell adhesion and PIA production-related gene expression.
- The small-molecule compound SYG-180-2-2 demonstrates potential as a safe and effective agent against MRSA biofilms.
- Further research into SYG-180-2-2 could lead to new therapeutic strategies for combating MRSA infections.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing

